REMSleep Holdings Inc (RMSL) Prévision du cours des actions

RemSleep Holdings, Inc. engages in the design and manufacture of medical devices and products for the treatment of sleep apnea and other respiratory conditions. The company is headquartered in Clearwater, Florida. The company went IPO on 2008-12-15. The Company’s focus is primarily on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. Its patented DeltaWave product is a nasal-pillow type interface that is designed with unique airflow characteristics to enable patients with sleep apnea to breathe normally. DeltaWave delivers comfort and airflow for better sleep and improved CPAP therapy. The Company’s product is manufactured by mold makers. The company has molds made in China. Its target market includes sleep product distributors that distribute its product; home care dealers; private sleep labs; product end users; physicians, particularly sleep physicians; medical groups; hospitals, and medical associations, such as the American Academy of Sleep Medicine and the American Sleep Association.